日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Case Report: Successful treatment of steroid-refractory severe immunotherapy-induced pneumonitis with equine antithymocyte globulin

病例报告:马抗胸腺细胞球蛋白成功治疗类固醇难治性重症免疫疗法诱发性肺炎

Luong, Thi Thao Vi; Lin, Lindon; Coutsouvelis, John; Dabscheck, Eli; Ivulich, Steven; Burridge, Hayley; Keating, Dominic; Shackleton, Mark; Haydon, Andrew; Andrews, Miles C

Expansion of a circulating Ki67-positive effector T-cell population following combined PD-1 and CTLA-4 blockade for melanoma is predictive of treatment response

黑色素瘤患者接受PD-1和CTLA-4联合阻断治疗后,循环中Ki67阳性效应T细胞群的扩增可预测治疗反应。

Edwards, Jack M; Senthi, Sashendra; Smith, Robin; Burridge, Hayley; Owens, Carole; Shackleton, Mark; Andrews, Miles C; van Zelm, Menno C

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

在超过 8000 名涵盖 24 种癌症类型的患者中,肿瘤突变负荷与免疫检查点抑制剂治疗后的生存率之间的关系

Gandara, David R; Agarwal, Neeraj; Gupta, Shilpa; Klempner, Samuel J; Andrews, Miles C; Mahipal, Amit; Subbiah, Vivek; Eskander, Ramez N; Carbone, David P; Riess, Jonathan W; Sammons, Sarah; Snider, Jeremy; Bouzit, Lilia; Cho-Phan, Cheryl; Price, Megan; Li, Gerald; Quintanilha, Julia C F; Huang, Richard Sheng Poe; Ross, Jeffrey S; Fabrizio, David; Oxnard, Geoffrey R; Graf, Ryon P

Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation.

根据黑色素含量对具有异质性疾病传播潜能的黑色素瘤细胞进行前瞻性分离

Fedele Clare, Kuser-Abali Gamze, Rossi Ralph, Zhao Peinan, Li Jason, Ameratunga Malaka, Szeto Pacman, Zhang YouFang, Andrews Miles, Shackleton Mark

Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma

肿瘤突变负荷对转移性黑色素瘤一线免疫检查点抑制剂真实世界疗效的预测影响

Andrews, Miles C; Li, Gerald; Graf, Ryon P; Fisher, Virginia A; Mitchell, Jerry; Aboosaiedi, Ali; O'Rourke, Harriet; Shackleton, Mark; Iddawela, Mahesh; Oxnard, Geoffrey R; Huang, Richard S P

Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years

肺移植术后恶性肿瘤风险和死亡率:一家机构31年的经验

Yeoh, Hui-Ling; Shingles, Helen; Paul, Eldho; Levvey, Bronwyn J; Schwarz, Max; Voskoboynik, Mark; Haydon, Andrew M; Shackleton, Mark; Snell, Gregory I; Andrews, Miles C

UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma

UHRF1/UBE2L6/UBR4介导的泛素化调控EZH2的丰度,从而影响黑色素瘤中黑色素细胞的分化表型。

Kuser-Abali, Gamze; Zhang, Youfang; Szeto, Pacman; Zhao, Peinan; Masoumi-Moghaddam, Samar; Fedele, Clare G; Leece, Isobel; Huang, Cheng; Cheung, Jen G; Ameratunga, Malaka; Noguchi, Fumihito; Andrews, Miles C; Wong, Nicholas C; Schittenhelm, Ralf B; Shackleton, Mark

Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation

对携带 BRAF 突变的黑色素瘤患者未经治疗的免疫微环境进行表征

Wang, Minyu; Zadeh, Soroor; Pizzolla, Angela; Thia, Kevin; Gyorki, David E; McArthur, Grant A; Scolyer, Richard A; Long, Georgina; Wilmott, James S; Andrews, Miles C; Au-Yeung, George; Weppler, Ali; Sandhu, Shahneen; Trapani, Joseph A; Davis, Melissa J; Neeson, Paul Joseph

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities

利用全面的癌症登记数据开展广泛的研究、审计和患者支持活动

Lee, Belinda; Gately, Lucy; Lok, Sheau Wen; Tran, Ben; Lee, Margaret; Wong, Rachel; Markman, Ben; Dunn, Kate; Wong, Vanessa; Loft, Matthew; Jalili, Azim; Anton, Angelyn; To, Richard; Andrews, Miles; Gibbs, Peter

Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study

免疫检查点抑制剂与高危或晚期黑色素瘤患者发生重大动脉粥样硬化性心血管事件风险:一项回顾性队列研究

Wang, Charlie; Zoungas, Sophia; Yan, Mabel; Wolfe, Rory; Haydon, Andrew; Shackleton, Mark; Voskoboynik, Mark; Moore, Maggie; Andrews, Miles C; Nicholls, Stephen J; Mar, Victoria